Lucid Diagnostics (LUCD) News Today $1.26 +0.06 (+5.00%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$1.25 -0.01 (-0.40%) As of 08/29/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock LUCD Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Canaccord Genuity Remains a Buy on Lucid Diagnostics (LUCD)August 29 at 5:32 PM | theglobeandmail.comLucid Diagnostics to Participate in the Cantor Global Healthcare Conference 2025August 27 at 8:00 AM | prnewswire.comPAVmed Signs Letter of Intent to License Groundbreaking Endoscopic Esophageal Imaging TechnologyAugust 26, 2025 | prnewswire.comInsider Buying: Lucid Diagnostics (NASDAQ:LUCD) Director Acquires 100,000 Shares of StockAugust 23, 2025 | insidertrades.comLucid Diagnostics (LUCD) Gets a Buy from BTIGAugust 22, 2025 | theglobeandmail.comLucid Diagnostics (NASDAQ:LUCD) Raised to "Hold" at Wall Street ZenAugust 17, 2025 | marketbeat.comNeedham & Company LLC Reaffirms "Buy" Rating for Lucid Diagnostics (NASDAQ:LUCD)August 15, 2025 | marketbeat.comLucid Diagnostics reports Q2 non-GAAP EPS (10c), consensus (10c)August 15, 2025 | msn.comPAVmed Provides Business Update and Reports Second Quarter 2025 Financial ResultsAugust 14, 2025 | prnewswire.comLucid Diagnostics Advances Towards Medicare CoverageAugust 14, 2025 | msn.comLucid Diagnostics Inc (LUCD) Q2 2025 Earnings Call Highlights: Revenue Surge and Strategic ...August 14, 2025 | finance.yahoo.comLucid Diagnostics Reports Q2 2025 EarningsAugust 13, 2025 | tipranks.comLucid Diagnostics Inc. (LUCD) Q2 2025 Earnings Call TranscriptAugust 13, 2025 | seekingalpha.comLucid Diagnostics Provides Business Update and Reports Second Quarter 2025 Financial ResultsAugust 13, 2025 | prnewswire.comWhat To Expect From Lucid Diagnostics Inc (LUCD) Q2 2025 EarningsAugust 12, 2025 | finance.yahoo.comLucid Diagnostics (LUCD) Projected to Post Quarterly Earnings on WednesdayAugust 6, 2025 | marketbeat.comLucid Diagnostics to Participate in Upcoming Investor ConferencesAugust 5, 2025 | prnewswire.comLucid Diagnostics Inc. (NASDAQ:LUCD) Given Consensus Rating of "Buy" by AnalystsAugust 5, 2025 | marketbeat.comPAVmed to Hold a Business Update Conference Call and Webcast on August 14, 2025July 31, 2025 | prnewswire.comPAVmed Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price RuleJuly 30, 2025 | finance.yahoo.comLucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 13, 2025July 30, 2025 | prnewswire.comLucid nearing Medicare coverage for EsoGuard test, maintain at Buy: BTIGJuly 28, 2025 | msn.comSargent Investment Group LLC Sells 498,000 Shares of Lucid Diagnostics Inc. (NASDAQ:LUCD)July 21, 2025 | marketbeat.comLucid says meeting scheduled to determine Medicare coverage for cancer testJuly 16, 2025 | msn.comLucid Diagnostics' (LUCD) Buy Rating Reaffirmed at Needham & Company LLCJuly 16, 2025 | marketbeat.comMolDX to Convene Expert Medical Panel on Medicare Local Coverage Determination (LCD) for Lucid Diagnostics' EsoGuard® Esophageal DNA TestJuly 16, 2025 | prnewswire.comLucid Diagnostics Inc News (LUCD) - Investing.comJuly 11, 2025 | investing.comLucid Diagnostics Inc. (NASDAQ:LUCD) Receives Average Recommendation of "Buy" from AnalystsJuly 11, 2025 | marketbeat.comMajor California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoGuard® Esophageal DNA TestJune 18, 2025 | prnewswire.comLucid Diagnostics Inc. (NASDAQ:LUCD) Short Interest Down 39.3% in MayJune 16, 2025 | marketbeat.comLucid Diagnostics Inc. (NASDAQ:LUCD) Given Consensus Rating of "Buy" by BrokeragesJune 16, 2025 | marketbeat.comAscendiant Capital Markets Forecasts Strong Price Appreciation for Lucid Diagnostics (NASDAQ:LUCD) StockJune 6, 2025 | marketbeat.comLucid Diagnostics Inc. (NASDAQ:LUCD) Sees Large Increase in Short InterestJune 3, 2025 | marketbeat.comLucid Diagnostics to Join Russell 2000® and Russell 3000® IndexesMay 27, 2025 | prnewswire.comLucid Diagnostics’ SWOT analysis: stock faces reimbursement hurdles amid market potentialMay 21, 2025 | investing.comLucid Diagnostics Reports Increased Losses Amid Revenue DeclineMay 15, 2025 | tipranks.comEarnings call transcript: Lucid Diagnostics Q1 2025 highlights growth and strategic expansionMay 15, 2025 | investing.comPAVmed Provides Business Update and Reports First Quarter 2025 Financial ResultsMay 15, 2025 | prnewswire.comLucid Diagnostics Inc. (LUCD) Q1 2025 Business Update Call TranscriptMay 14, 2025 | seekingalpha.comLucid Diagnostics Provides Business Update and Reports First Quarter 2025 Financial ResultsMay 14, 2025 | prnewswire.comLucid Diagnostics (LUCD) to Release Earnings on WednesdayMay 9, 2025 | marketbeat.comLucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025April 30, 2025 | prnewswire.comLucid Diagnostics’ EsoGuard DNA Test shows cancer detection efficacy in studyApril 26, 2025 | markets.businessinsider.comLucid Diagnostics Reports Positive Data for EsoGuard in Study of Asymptomatic PatientsApril 24, 2025 | theglobeandmail.comLucid reports encouraging results from EsoGuard studyApril 24, 2025 | msn.comNCI-Sponsored Study Shows Positive Data for Lucid Diagnostics' EsoGuard® Esophageal DNA Test in Patients Without Symptomatic GERDApril 24, 2025 | prnewswire.comAscendiant Capital Markets Issues Positive Forecast for Lucid Diagnostics (NASDAQ:LUCD) Stock PriceApril 23, 2025 | marketbeat.comLucid Diagnostics price target raised to $7.50 from $7 at AscendiantApril 22, 2025 | markets.businessinsider.comLucid Diagnostics (NASDAQ:LUCD) Earns "Buy" Rating from Needham & Company LLCApril 13, 2025 | marketbeat.comLucid Diagnostics Closes $16.1 Million Public OfferingApril 11, 2025 | tipranks.com Get Lucid Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for LUCD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LUCD Media Mentions By Week LUCD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LUCD News Sentiment▼0.821.05▲Average Medical News Sentiment LUCD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LUCD Articles This Week▼52▲LUCD Articles Average Week Get the Latest News and Ratings for LUCD and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Lucid Diagnostics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies SMLR News CBLL News DCTH News SNWV News BFLY News RXST News CLPT News SMTI News NPCE News TCMD News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LUCD) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lucid Diagnostics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lucid Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LUCD Stock Alerts